Abstract
Trading pharmaceutical products through the Internet poses several challenges related to legal responsibilities, good distribution practices, information content and patient use, financial implications, but also regarding product quality. One of the major concerns is the well-known phenomenon of counterfeited and/or substandard drugs commercialized through rogue Internet sites. Therefore, controlling and assuring the quality of those products has become an important and challenging task for the authorities. This review gives an overview of the different quality attributes that can be evaluated to have a complete understanding of the quality of the finished pharmaceutical product traded through the Internet, as well as the current analytical techniques that serve this objective. Aspects considered are labelling and packaging, physicochemical quality attributes, identification and assay of active substances and/or excipients, impurity profiling, biopharmaceutical testing and data interpretation.
Similar content being viewed by others
References
Bloom BS, Iannacone RC (2006) Med Inform Internet Med 31:247–253
Bloom BS, Iannacone RC (1999) Ann Intern Med 131:830–833
Lorence D, Churchill R (2007) J Med Syst 31:551–556
Bostwick JM, Lineberry TW (2007) Expert Opin Drug Saf 6:9–13
Liang BA, Mackey T (2009) Am J Law Med 35:125–184
Baldas T, Natl Law J (2009) http://www.law.com/jsp/nlj/PubArticleNLJ.jsp?id=1202431938670&hbxlogin=1
United States Food and Drug Administration (2007) FDA finds consumers continue to buy potentially risky drugs over the Internet. Practice puts consumers at risk and may be more expensive than domestic purchasing. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108946.htm
Lowe RF, Montagu D (2009) S Med Rev 2:35–44
The Pharmaceutical Society of Northern Ireland (2009) Professional standards and guidance for Internet pharmacy services. http://psni.org.uk/documents/316/Standards+on+Internet+Pharmacy.pdf. Accessed 1 Jun 2010
European Alliance for Access to Safe Medicines (2008) The counterfeiting superhighway. Medicon Group Ltd, Surrey, UK
Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (2009) Koninklijk besluit van 21 januari 2009 houdende onderrichtingen voor de apothekers. Belgisch Staatsblad, Brussels, Belgium
United States Food and Drug Administration (2010) Buying medicines over the Internet. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/BuyingMedicinesOvertheInternet/default.htm. Accessed 1 Jun 2010
State Food and Drug Administration P.R. China (2001) Drug administration law of the People's Republic of China. http://eng.sfda.gov.cn/cmsweb/webportal/W45649037/A48335975.html. Accessed 1 Jun 2010
Newton PN et al (2006) Lancet Infect Dis 6:602–613
Rodionova OY et al (2005) Anal Chim Acta 549:151–158
World Health Organization (2010) Medicines: counterfeit medicines. http://www.who.int/mediacentre/factsheets/fs275/en/index.html. Accessed 1 Jun 2010
Veronin MA, Lee E, Lewis EN (2007) Ann Pharmacother 41:1111–1115
Maurin JK et al (2007) J Pharm Biomed Anal 43:1514–1518
Vivian JC (2009) US Pharm 34:42–45
Connor TH et al (2005) Am J Health Syst Pharm 62:475–484
Westenberger BJ et al (2005) Int J Pharm 306:56–70
Wood S et al (2009) Packag Dig 46(8):28–30
Green MD et al (2007) J Pharm Biomed Anal 43:105–110
De Spiegeleer B et al (2008) Anal Biochem 376:229–234
Kaye ST (2007) Rapid pharmaceutical identification and verification system. US Patent 7(218):395
Kenyon TA et al (1999) Int J Tuberc Lung Dis 3:S347–S350
Joseph-Charles J et al (2007) J Pharm Biomed Anal 44:1008–1013
Lindegardh N et al (2006) J Pharm Biomed Anal 42:430–433
Onwujekwe O et al (2009) Malaria J 8:22
Baert B et al (2009) Eur J Pharm Biopharm 72:275–281
Sengaloundeth S et al (2009) Malaria J 8:172
Veronin MA, Nguyen NT (2008) Ann Pharmacother 42:613–620
Arthur KE, Wolff JC, Carrier DJ (2004) Rapid Commun Mass Spectrom 18:678–684
Alabdalla MA (2005) Forensic Sci Int 152:185–188
Uchiyama N et al (2009) Yakugaku Zasshi 130:263–270
Patnala S, Kanfer I (2008) J Pharm Biomed Anal 48:440–446
Wolff JC, Thomson LA, Eckers C (2003) Rapid Commun Mass Spectrom 17:215–221
Ricci C et al (2007) Anal Bioanal Chem 387:551–559
Ricci C et al (2008) Anal Chim Acta 623:178–186
Nyadong L et al (2009) Anal Chem 81:4803–4812
Steiner RR, Larson RL (2009) J Forensic Sci 54:617–622
Fernandez FM et al (2006) ChemMedChem 1:702–705
Shin YS et al (2007) Anal Chem 79:3514–3518
Cody RB (2009) Anal Chem 81:1101–1107
Nyadong L, Galhena AS, Fernandez FM (2009) Anal Chem 81:7788–7794
Haddad R et al (2008) Anal Chem 80:2744–2750
O'Donnell RM, Sun X, Harrington PDB (2008) Trends Anal Chem 27:44–53
AlHussaini SR (1996) Sci Justice 36:139–142
Lopes MB, Wolff JC (2009) Anal Chim Acta 633:149–155
Lei Y, Luo ZY, Hu CQ (2008) J Near Infrared Spectrosc 16:349–355
Ricci C, Kazarian SG (2006) In: Lewis C, Owen GP (eds) Optics and photonics for counterterrorism and crime fighting II. SPIE-International Society for Optical Engineering. Bellingham, Washington, USA
Ricci C (2007) Anal Bioanal Chem 389:1525–1532
de Veij M et al (2007) J Raman Spectrosc 38:181–187
Trefi S et al (2008) J Pharm Biomed Anal 47:103–113
de Veij M et al (2008) J Pharm Biomed Anal 46:303–309
Blanco M et al (2006) J Pharm Sci 95:2137–2144
Puchert T et al (2010) J Pharm Biomed Anal 51:138–145
Balayssac S et al (2009) Spectrosc Eur 21:10–14
Trefi S et al (2009) Magn Reson Chem 47:S163–S173
Shah H (1992) Perspect Pharm Econ 4:3
Adegbolagun O, Olalade O, Osumah S (2007) Trop J Pharm Res 6:737–745
Tipke M et al (2008) Malaria J 7:95
Shah VP (2005) In: Dressman J, Krämer J (eds) Pharmaceutical dissolution testing. Taylor & Francis, New York
Loebenberg R (2008) Dissolution testing and quality by design (QbD). http://www.scitopics.com/Dissolution_Testing_and_Quality_by_Design_QbD.html
Amin A, Kokwaro G (2007) Clin Pharm Ther 32:429–440
Thakker KD, Chern WD (2003) Dissolut Technol 10:10–15
Laserson KF et al (2001) Int J Tuberc Lung Dis 5:448–454
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baert, B., De Spiegeleer, B. Quality analytics of internet pharmaceuticals. Anal Bioanal Chem 398, 125–136 (2010). https://doi.org/10.1007/s00216-010-3912-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3912-4